Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)

Details

Ressource 1Download: serval:BIB_C6FF10774C6D.P001 (229.80 [Ko])
State: Public
Version: author
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_C6FF10774C6D
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
Title
Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)
Journal
Annals of Oncology
Author(s)
Wasserfallen  J. B., Rollier  P., Leyvraz  S., Perey  L.
ISSN
0923-7534 (Print)
Publication state
Published
Issued date
02/1999
Volume
10
Number
2
Pages
243-4
Notes
Comparative Study
Letter --- Old month value: Feb
Keywords
Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carcinoma, Small Cell/*drug therapy Cisplatin/administration & dosage Doxorubicin/administration & dosage Etoposide/administration & dosage Health Care Costs *Hematopoietic Stem Cell Transplantation Humans Ifosfamide/administration & dosage Lung Neoplasms/*drug therapy Middle Aged
Pubmed
Web of science
Open Access
Yes
Create date
28/01/2008 9:31
Last modification date
25/09/2019 7:10
Usage data